📰 Checkmate 214 News
Checkmate 214 News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Checkmate 214. Real-time updates on events, politics, business and more.
February 23, 2024
The expert panel discusses the 8-year follow-up data from CheckMate 214 looking at nivolumab plus ipilimumab in first-line advanced RCC and provide clinical insights on treatment decisions.
October 18, 2023
An overview of the treatment protocol for patients with advanced RCC who are receiving IO/TKI or IO/IO combination therapy.
May 22, 2023
Key opinion leaders in the field of renal cell carcinoma management discuss the advent of combination immunotherapy in patients with metastatic disease.
March 24, 2023
Renal cell carcinoma experts discuss clinical trials, evaluating immunotherapies and tyrosine kinase inhibitors in the front line setting of advanced RCC.